Monday, October 20, 2014
Inquirer Daily News

Got back pain? Glucosamine won't help.

Chronic back pain in a common problem in the U.S. afflicting more than 20 million people. Many turn to the supplement glucosamine, despite little solid evidence that it helps people suffering from chronic back pain or joint pain caused by osteoarthritis. The researchers at Oslo University in Norway randomly assigned 250 people with chronic back pain due to osteoarthritis to two groups - one got the glucosamine and the other took placebos. The researchers reported "no statistically significant difference in change between groups was found when assessed after the 6-month intervention and at 1 year."

Got back pain? Glucosamine won’t help.

Chronic back pain in a common problem in the U.S. afflicting more than 20  million people. Many turn to the supplement glucosamine, despite little solid evidence that it helps people suffering from chronic back pain or joint pain caused by osteoarthritis.

A study published in the current issue of the Journal of the American Medical Association reports that daily intake of 1,500 milligrams of the supplement for six months did not reduce “pain-related disability.”

The researchers at Oslo University in Norway randomly assigned 250 people with chronic back pain due to osteoarthritis to two groups – one got the glucosamine and the other took placebos. The researchers reported “no statistically significant difference in change between groups was found when assessed after the 6-month intervention and at 1 year.”

“Based on our results it seems unwise to recommend glucosamine to all patients with chronic [lower back pain] and degenerative lumbar osteoarthritis,” the researchers concluded.

To check out more Check Up items go to www.philly.com/checkup.

About this blog

Check Up covers major health events in our region and offers everything from personal health advice to an expert look at health reform. Read about some of our bloggers here.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Latest Health Videos
Also on Philly.com:
Stay Connected